412 filings
Page 13 of 21
8-K
o5udsrchd
3 Nov 16
Trevena Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
4
ymakteblj5vjgf7y6
25 Oct 16
TREVENA / MAXINE GOWEN ownership change
12:00am
4
qq28urf
19 Oct 16
TREVENA / MAXINE GOWEN ownership change
12:00am
CT ORDER
6xg3f80fbufq 064
1 Sep 16
Confidential treatment order
12:00am
8-K
q4hhn7izm30250so08
4 Aug 16
Trevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update
12:00am
4
t3gc t6rea
31 May 16
TREVENA / MAXINE GOWEN ownership change
12:00am
4
hr5v16xo
19 May 16
TREVENA / Julie McHugh ownership change
12:00am
4
yim561o8fyr7atj5r4w
19 May 16
TREVENA / Jason Raleigh Nunn ownership change
12:00am
4
i4bar n9pd
19 May 16
TREVENA / Adam Koppel ownership change
12:00am
4
2nv30s2y3193gce
19 May 16
TREVENA / Barbara Yanni ownership change
12:00am
8-K
yca2orygv vmex
19 May 16
Submission of Matters to a Vote of Security Holders
12:00am
4
4kyh32gywwem
19 May 16
TREVENA / LEON O MOULDER JR ownership change
12:00am
4
ddaz3bno7n6gu2
19 May 16
TREVENA / Anne M. Phillips ownership change
12:00am
4
1uyrqcsjy4y 2vc6s9j
19 May 16
TREVENA / MICHAEL R DOUGHERTY ownership change
12:00am
8-K
be8 n5cnctkpnvx
16 May 16
Trevena Reports TRV027 Did Not Achieve Primary or Secondary Endpoints in BLAST-AHF Phase 2b Trial in Acute Heart Failure
12:00am
8-K
79nnnk yvf0
5 May 16
Trevena Reports First Quarter 2016 Financial Results
12:00am
8-K
7ajx unxscuw25nan34
2 May 16
Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine
12:00am